Evidence map›Paper›PMID 35577395›Full record

ArticleStroke and vascular neurology2022

Long-term modification of gut microbiota by broad-spectrum antibiotics improves stroke outcome in rats.

Chang Liu, Xi Cheng, Shanshan Zhong, Zhouyang Liu, Fangxi Liu, Xinyu Lin, Yinan Zhao, Meiting Guan, Ting Xiao, Jukka Jolkkonen and 2 more

Open access · goldAbstract read
In one paragraph

Article in Stroke and vascular neurology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 23 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Review
  12. Review
  13. Review
  14. Review
  15. Review
  16. Review
  17. Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 2 countries.

Chang LiuDepartment of Neurology, The First Hospital of China Medical University, Shenyang, Liaoning, China.
Xi ChengDepartment of Neurology, The First Hospital of China Medical University, Shenyang, Liaoning, China.
Shanshan ZhongDepartment of Neurology, The First Hospital of China Medical University, Shenyang, Liaoning, China.
Zhouyang LiuDepartment of Neurology, The First Hospital of China Medical University, Shenyang, Liaoning, China.
Fangxi LiuDepartment of Neurology, The First Hospital of China Medical University, Shenyang, Liaoning, China.
Xinyu LinDepartment of Neurology, The First Hospital of China Medical University, Shenyang, Liaoning, China.
Yinan ZhaoDepartment of Neurology, The First Hospital of China Medical University, Shenyang, Liaoning, China.
Meiting GuanDepartment of Neurology, The First Hospital of China Medical University, Shenyang, Liaoning, China.
Ting XiaoDepartment of Dermatology, The First Hospital of China Medical University, Shenyang, Liaoning, China.
Jukka JolkkonenA.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland.
Ying WangDepartment of Neurology, First Affiliated Hospital of Dalian Medical University, Dalian, China.
Chuansheng ZhaoDepartment of Neurology, The First Hospital of China Medical University, Shenyang, Liaoning, China cszhao@cmu.edu.cn.ORCID 0000-0002-4100-1259
First Hospital of China Medical University · CNDalian Medical University · CNMinistry of Education of the People's Republic of China · CNUniversity of Eastern Finland · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe brain-gut axis is a major regulator of the central nervous system. We investigated the effects of treatment with broad-spectrum antibiotics on gut and brain inflammation, infarct size and long-term behavioral outcome after cerebral ischemia in rats.

methodsRats were treated with broad-spectrum antibiotics (ampicillin, vancomycin, ciprofloxacin, meropenem and metronidazole) for 4 weeks before the endothelin-1 induced ischemia. Treatment continued for 2 weeks until the end of behavioral testing, which included tapered ledged beam-walking, adhesive label test and cylinder test. Gut microbiome, short-chain fatty acids and cytokine levels were measured together with an assessment of infarct size, neuroinflammation and neurogenesis.

resultsThe results revealed that the antibiotics exerted a clear impact on the gut microbiota. This was associated with a decrease in systemic and brain cytokine levels, infarct size and apoptosis in the perilesional cortex and improved behavioral outcome.

conclusionOur results highlighted the significant relationship between intestinal microbiota and beneficial neuro-recovery after ischemic stroke.

Indexed as

Gastrointestinal MicrobiomeStrokeAmpicillinAnimalsAnti-Bacterial AgentsCiprofloxacinCytokinesEndothelin-1Fatty Acids, VolatileInfarctionMeropenemMetronidazoleRatsVancomycinAmpicillinAnti-Bacterial AgentsCiprofloxacinCytokinesEndothelin-1Fatty Acids, VolatileMeropenemMetronidazoleVancomycinCerebral InfarctionStrokeStroke Rehabilitation

Identifiers

PMID35577395
PMCPMC9614136
OpenAlexW4280602462

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.